Novo Integrated Sciences (NVOS)

Company Profile

novo integrated sciences, inc., together with its subsidiaries, provides primary healthcare services. it offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-ptsd, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. the company also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions. in addition, it offers specialty treatment and recovery program

Company profile

Ticker

NVOS

Exchange

NASDAQ

Website

novointegrated.com

CEO

Robert Mattacchione

Incorporated

Nevada

Location

Washington

Fiscal year end

Aug 31

Sector

Manufacturing > Motor Vehicle Gasoline Engine and Engine Parts Manufacturing

Industry (SIC)

Engines & Turbines

Cummins • BWX • Brunswick • Westport Fuel Systems • TPI Composites • Power Solutions International • Capstone Green Energy • Unrivaled Brands • Regi U S • Carnegie Development ...

Former names

TURBINE TRUCK ENGINES INC

SEC CIK

0001138978

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Novo Healthnet Limited • Novomerica Health Group, Inc. • PRO-DIP, LLC • Acenzia, Inc. • Terragenx Inc. • Clinical Consultants International LLC • Novo Healthnet Rehab Limited • Novo Assessments Inc. • Novo Healthnet Kemptville Centre, Inc. • 12858461 Canada Corp. ...

NVOS stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K

Entry into a Material Definitive Agreement

22 Sep 23

DEFA14A

Additional proxy soliciting materials

21 Sep 23

8-K

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

21 Sep 23

8-K

Entry into a Material Definitive Agreement

18 Sep 23

8-K

Novo Integrated Sciences’ IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health

13 Sep 23

8-K

Novo Integrated Sciences Provides Update on Potential Share Repurchase Program

8 Sep 23

8-K

Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon

31 Aug 23

8-K

Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

30 Aug 23

8-K

Regulation FD Disclosure

24 Aug 23

8-K

Novo Integrated Sciences’ IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health

22 Aug 23

Latest ownership filings

View all

Christopher Mehlin David

2 Jun 23

SC 13G/A

Hudson Bay Capital Management LP

Robert Letterio Oliva

21 Apr 22

Robert Letterio Oliva

Hudson Bay Capital Management LP

8 Feb 22

SC 13G

Hudson Bay Capital Management LP

8 Feb 22

Financial summary

Financial statements Chart NVOS financial data

Quarter (USD)	May 23	Feb 23	Nov 22	Aug 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Aug 22	Aug 21	Aug 20	Aug 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	464.01 k	464.01 k	464.01 k	464.01 k	464.01 k	464.01 k
Cash burn (monthly)	48.58 k	1.02 mm	495.10 k	2.73 mm	285.91 k	111.57 k
Cash used (since last report)	183.74 k	3.85 mm	1.87 mm	10.31 mm	1.08 mm	422.00 k
Cash remaining	280.27 k	-3.39 mm	-1.41 mm	-9.85 mm	-617.44 k	42.01 k
Runway (months of cash)	5.8	-3.3	-2.8	-3.6	-2.2	0.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2023

NVOS institutional ownership history Ownership history

1.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	13	6	+116.7%
Opened positions	10	3	+233.3%
Closed positions	3	11	-72.7%
Increased positions	1	2	-50.0%
Reduced positions	1	1	–

13F shares	Current	Prev Q	Change
Total value	290.07 mm	8.89 mm	+3162.5%
Total shares	2.19 mm	284.81 k	+670.4%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Geode Capital Management	816.60 k	$120.94 mm	NEW
STT State Street	290.19 k	$42.98 mm	NEW
Vanguard	238.86 k	$35.38 mm	NEW
Virtu Financial	233.48 k	$35.00 k	+78.5%
UBS UBS Group AG - Registered Shares	138.14 k	$20.45 mm	NEW
Cubist Systematic Strategies	130.13 k	$19.27 mm	NEW
NTRS Northern Trust	88.89 k	$13.17 mm	NEW
RY Royal Bank Of Canada	76.39 k	$11.00 mm	NEW
Two Sigma Securities	64.48 k	$9.55 mm	NEW
Axxcess Wealth Management	55.00 k	$8.15 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Geode Capital Management	816.60 k	+816.60 k	NEW
STT State Street	290.19 k	+290.19 k	NEW
Vanguard	238.86 k	+238.86 k	NEW
UBS UBS Group AG - Registered Shares	138.14 k	+138.14 k	NEW
Cubist Systematic Strategies	130.13 k	+130.13 k	NEW
Virtu Financial	233.48 k	+102.70 k	+78.5%
NTRS Northern Trust	88.89 k	+88.89 k	NEW
RY Royal Bank Of Canada	76.39 k	+76.39 k	NEW
Two Sigma Securities	64.48 k	+64.48 k	NEW
Tower Research Capital	48.82 k	-33.02 k	-40.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NVOS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
31 May 23	Christopher Mehlin David	Stock Option Common Stock	Grant	Acquire A	No	No	0.132	2,000,000	264.00 k	2,000,000
9 Aug 22	Sarfaraz Ali	Stock Option Common Stock	Grant	Acquire A	No	No	1.9	39,480	75.01 k	39,480
20 Apr 22	Robert Letterio Oliva	Common Stock	Buy	Acquire P	No	No	2.25	300	675.00	217,717
20 Apr 22	Robert Letterio Oliva	Common Stock	Buy	Acquire P	No	No	2.23	4,700	10.48 k	217,417
19 Apr 22	Robert Letterio Oliva	Common Stock	Buy	Acquire P	No	No	2.225	5,000	11.13 k	212,717